GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Cyclically Adjusted PS Ratio

Bioton (LTS:0DTR) Cyclically Adjusted PS Ratio : 0.87 (As of Jun. 02, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bioton Cyclically Adjusted PS Ratio?

As of today (2024-06-02), Bioton's current share price is zł3.42829. Bioton's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was zł3.93. Bioton's Cyclically Adjusted PS Ratio for today is 0.87.

The historical rank and industry rank for Bioton's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0DTR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.45   Med: 0.95   Max: 1.43
Current: 0.86

During the past years, Bioton's highest Cyclically Adjusted PS Ratio was 1.43. The lowest was 0.45. And the median was 0.95.

LTS:0DTR's Cyclically Adjusted PS Ratio is ranked better than
87.1% of 504 companies
in the Biotechnology industry
Industry Median: 5.425 vs LTS:0DTR: 0.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bioton's adjusted revenue per share data for the three months ended in Mar. 2024 was zł0.437. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is zł3.93 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bioton Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bioton's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Cyclically Adjusted PS Ratio Chart

Bioton Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 1.04 1.02 0.79 0.86

Bioton Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.84 0.92 0.86 0.87

Competitive Comparison of Bioton's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Bioton's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bioton's Cyclically Adjusted PS Ratio falls into.



Bioton Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bioton's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.42829/3.93
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioton's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bioton's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.437/149.0435*149.0435
=0.437

Current CPI (Mar. 2024) = 149.0435.

Bioton Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.931 101.180 1.371
201409 1.244 100.611 1.843
201412 1.327 100.122 1.975
201503 1.079 100.041 1.608
201506 1.138 100.448 1.689
201509 1.312 99.634 1.963
201512 0.344 99.471 0.515
201603 0.793 98.983 1.194
201606 0.902 99.552 1.350
201609 0.887 99.064 1.335
201612 0.650 100.366 0.965
201703 0.811 101.018 1.197
201706 0.999 101.180 1.472
201709 1.071 101.343 1.575
201712 1.331 102.564 1.934
201803 0.537 102.564 0.780
201806 0.990 103.378 1.427
201809 0.572 103.378 0.825
201812 0.710 103.785 1.020
201903 0.358 104.274 0.512
201906 0.842 105.983 1.184
201909 0.523 105.983 0.735
201912 0.629 107.123 0.875
202003 0.432 109.076 0.590
202006 0.585 109.402 0.797
202009 0.506 109.320 0.690
202012 1.060 109.565 1.442
202103 0.429 112.658 0.568
202106 0.425 113.960 0.556
202109 0.557 115.588 0.718
202112 0.487 119.088 0.609
202203 0.583 125.031 0.695
202206 0.560 131.705 0.634
202209 0.670 135.531 0.737
202212 0.903 139.113 0.967
202303 0.400 145.950 0.408
202306 0.571 147.009 0.579
202309 0.590 146.113 0.602
202312 0.553 147.741 0.558
202403 0.437 149.044 0.437

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bioton  (LTS:0DTR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bioton Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bioton's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioton (LTS:0DTR) Business Description

Industry
Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines